These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 24611762)
1. Controlled apoptosis by a thermally toggled nanoscale amplifier of cellular uptake. MacEwan SR; Chilkoti A Nano Lett; 2014; 14(4):2058-64. PubMed ID: 24611762 [TBL] [Abstract][Full Text] [Related]
2. A smart polymeric platform for multistage nucleus-targeted anticancer drug delivery. Zhong J; Li L; Zhu X; Guan S; Yang Q; Zhou Z; Zhang Z; Huang Y Biomaterials; 2015 Oct; 65():43-55. PubMed ID: 26142775 [TBL] [Abstract][Full Text] [Related]
3. Polypeptide-engineered DNA tetrahedrons for targeting treatment of colorectal cancer via apoptosis and autophagy. Zhang N; Yang Y; Wang Z; Yang J; Chu X; Liu J; Zhao Y J Control Release; 2019 Sep; 309():48-58. PubMed ID: 31301339 [TBL] [Abstract][Full Text] [Related]
4. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides. Dissanayake S; Denny WA; Gamage S; Sarojini V J Control Release; 2017 Mar; 250():62-76. PubMed ID: 28167286 [TBL] [Abstract][Full Text] [Related]
5. Penetrating the cell membrane, thermal targeting and novel anticancer drugs: the development of thermally targeted, elastin-like polypeptide cancer therapeutics. Ryu JS; Kuna M; Raucher D Ther Deliv; 2014 Apr; 5(4):429-45. PubMed ID: 24856169 [TBL] [Abstract][Full Text] [Related]
6. Intracellularly Actuated Quantum Dot-Peptide-Doxorubicin Nanobioconjugates for Controlled Drug Delivery via the Endocytic Pathway. Sangtani A; Petryayeva E; Wu M; Susumu K; Oh E; Huston AL; Lasarte-Aragones G; Medintz IL; Algar WR; Delehanty JB Bioconjug Chem; 2018 Jan; 29(1):136-148. PubMed ID: 29191007 [TBL] [Abstract][Full Text] [Related]
7. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide. Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251 [TBL] [Abstract][Full Text] [Related]
8. Self-Assembled Peptide-Lanthanide Nanoclusters for Safe Tumor Therapy: Overcoming and Utilizing Biological Barriers to Peptide Drug Delivery. Yan J; He W; Yan S; Niu F; Liu T; Ma B; Shao Y; Yan Y; Yang G; Lu W; Du Y; Lei B; Ma PX ACS Nano; 2018 Feb; 12(2):2017-2026. PubMed ID: 29376322 [TBL] [Abstract][Full Text] [Related]
9. Nanoscale Biodegradable Organic-Inorganic Hybrids for Efficient Cell Penetration and Drug Delivery. Hörner S; Knauer S; Uth C; Jöst M; Schmidts V; Frauendorf H; Thiele CM; Avrutina O; Kolmar H Angew Chem Int Ed Engl; 2016 Nov; 55(47):14842-14846. PubMed ID: 27774725 [TBL] [Abstract][Full Text] [Related]
10. Peptide chemistry encounters nanomedicine: recent applications and upcoming scenarios in cancer. Falanga A; Galdiero S Future Med Chem; 2018 Aug; 10(16):1877-1880. PubMed ID: 29921135 [No Abstract] [Full Text] [Related]
11. Enhanced intracellular peptide delivery by multivalent cell-penetrating peptide with bioreducible linkage. Kim H; Kitamatsu M; Ohtsuki T Bioorg Med Chem Lett; 2018 Feb; 28(3):378-381. PubMed ID: 29275934 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides. Gao W; Xiang B; Meng TT; Liu F; Qi XR Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200 [TBL] [Abstract][Full Text] [Related]
13. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide. Kanwar JR; Gibbons J; Verma AK; Kanwar RK Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171 [TBL] [Abstract][Full Text] [Related]
14. Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy. Bidwell GL; Raucher D Mol Cancer Ther; 2005 Jul; 4(7):1076-85. PubMed ID: 16020665 [TBL] [Abstract][Full Text] [Related]
16. Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide. Feni L; Parente S; Robert C; Gazzola S; Arosio D; Piarulli U; Neundorf I Bioconjug Chem; 2019 Jul; 30(7):2011-2022. PubMed ID: 31243977 [TBL] [Abstract][Full Text] [Related]
17. Delivery of a Proapoptotic Peptide to EGFR-Positive Cancer Cells by a Cyclic Peptide Mimicking the Dimerization Arm Structure of EGFR. Toyama K; Nomura W; Kobayakawa T; Tamamura H Bioconjug Chem; 2018 Jun; 29(6):2050-2057. PubMed ID: 29763296 [TBL] [Abstract][Full Text] [Related]
18. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth. Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853 [TBL] [Abstract][Full Text] [Related]
19. Self-assembled peptide nanoparticles for efficient delivery of methotrexate into cancer cells. Zakeri-Milani P; Shirani A; Nokhodchi A; Mussa Farkhani S; Mohammadi S; Shahbazi Mojarrad J; Mahmoudian M; Gholikhani T; Farshbaf M; Valizadeh H Drug Dev Ind Pharm; 2020 Apr; 46(4):521-530. PubMed ID: 32116040 [TBL] [Abstract][Full Text] [Related]
20. Design of a new pH-activatable cell-penetrating peptide for drug delivery into tumor cells. Zhang Y; Li L; Chang L; Liu H; Song J; Liu Y; Bao H; Liu B; Wang R; Ni J Chem Biol Drug Des; 2019 Sep; 94(5):1884-1893. PubMed ID: 31062442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]